Skip to main content
logo
Genmab A/S (GMAB)
NASDAQ: GMAB · Real-Time Price · USD
27.91
+0.25 (0.90%)
Mar 4, 2026, 10:57 AM EST - Market open

Genmab Revenue

In the year 2025, Genmab had annual revenue of $3.72B with 19.19% growth. Genmab had revenue of $1.06B in the quarter ending December 31, 2025, with 3.03% growth.

Revenue (ttm)
$3.72B
Revenue Growth
+19.19%
P/S Ratio
4.53
Revenue / Employee
$1,251,261
Employees
2,973
Market Cap
16.84B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20253.72B599.00M19.19%
Dec 31, 20243.12B731.00M30.59%
Jan 1, 20242.39B305.95M14.68%
Dec 31, 20222.08B796.62M61.88%
Dec 31, 20211.29B-374.23M-22.52%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Incyte5.14B
Jazz Pharmaceuticals4.27B
BioNTech SE3.70B
Royalty Pharma2.38B
Moderna1.94B
Ionis Pharmaceuticals943.71M
Ascendis Pharma845.52M
BridgeBio Pharma502.08M
Revenue Rankings

GMAB News

More News